NCT03306472 2024-01-30
PIONEER
Cambridge University Hospitals NHS Foundation Trust
Phase 2 Completed
Clinical Trials
9 trialsNCT03283488 2023-07-07
Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
University of Sao Paulo
Phase 2 Completed
NCT00006799 2021-09-09
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer
Wake Forest University Health Sciences
Phase 3 Completed
NCT00031785 2021-09-09
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Wake Forest University Health Sciences
Phase 3 Completed
NCT00483327 2018-04-04
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
NYU Langone Health
Phase 2 Completed
NCT00031707 2016-07-14
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00066248 2014-02-03
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
University of South Florida
Phase 2 Completed
NCT00002680 2013-07-24
Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
Yale University
Phase 2 Completed
NCT00004912 2012-05-30
Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
Northwestern University
Phase 2 Completed